Mobile Health Program for Heart Defects

This trial explores a mobile health program called Heart2Heart, designed for teens with congenital heart disease (a heart condition present at birth). The goal is to determine what teens like about the app and whether they find it easy to use. Participants will complete online surveys, use the app, and join an interview to share their thoughts. Teens aged 12 to 18 with this heart condition are suitable for the trial, provided they can participate in surveys and interviews in English and remain in the U.S. during the study. As an unphased trial, this study offers a unique opportunity for teens to shape a tool that could enhance their health management.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that the Heart2Heart mobile health program is undergoing testing to assist teens with congenital heart disease. As a mobile app, it lacks the typical risks associated with drug trials or medical procedures. No reports of negative effects have emerged from using mobile health tools like Heart2Heart. The program offers information and interactive features to educate teens on maintaining health. While traditional safety data, such as side effects, do not apply, the program is intended to be safe for users.¹²³⁴⁵

Researchers are excited about Heart2Heart because it offers a fresh approach to managing congenital heart disease in teens. Unlike traditional treatments that focus on medication or surgery, Heart2Heart is a mobile health program that provides educational content and interactive tools directly to a teenager's smartphone. This accessibility encourages teens to engage with their health in a more proactive way, potentially leading to better long-term outcomes by fostering healthy habits. Additionally, its interactive features are designed to keep teens interested and informed, which is a unique advantage over standard care options.

Research has shown that mobile health programs can enhance the quality, access, and efficiency of health care for specific groups, such as those with congenital heart disease (CHD). In this trial, participants in the Mobile Health Program arm will access Heart2Heart, a mobile health program specifically designed for teens with CHD. While specific data on Heart2Heart's effectiveness is not yet available, mobile health tools have shown promise in helping teens learn to manage their health. These programs often include interactive features and information that guide users in making healthier choices. For teens with CHD, this approach could improve their understanding and management of their condition. Early indications suggest that Heart2Heart might effectively educate and support teens in maintaining health with CHD.¹²⁵⁶⁷